494 related articles for article (PubMed ID: 17063460)
21. The nitric oxide-donating derivative of acetylsalicylic acid, NCX 4016, stimulates glucose transport and glucose transporters translocation in 3T3-L1 adipocytes.
Kaddai V; Gonzalez T; Bolla M; Le Marchand-Brustel Y; Cormont M
Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E162-9. PubMed ID: 18492771
[TBL] [Abstract][Full Text] [Related]
22. Telmisartan increases localization of glucose transporter 4 to the plasma membrane and increases glucose uptake via peroxisome proliferator-activated receptor γ in 3T3-L1 adipocytes.
Furukawa H; Mawatari K; Koyama K; Yasui S; Morizumi R; Shimohata T; Harada N; Takahashi A; Nakaya Y
Eur J Pharmacol; 2011 Jun; 660(2-3):485-91. PubMed ID: 21514293
[TBL] [Abstract][Full Text] [Related]
23. Peroxisome proliferator-activated receptor gamma agonists inhibit adipocyte expression of alpha1-acid glycoprotein.
Castriota G; Thompson GM; Lin Y; Scherer PE; Moller DE; Berger JP
Cell Biol Int; 2007 Jun; 31(6):586-91. PubMed ID: 17240171
[TBL] [Abstract][Full Text] [Related]
24. Daidzein and the daidzein metabolite, equol, enhance adipocyte differentiation and PPARgamma transcriptional activity.
Cho KW; Lee OH; Banz WJ; Moustaid-Moussa N; Shay NF; Kim YC
J Nutr Biochem; 2010 Sep; 21(9):841-7. PubMed ID: 19775880
[TBL] [Abstract][Full Text] [Related]
25. Chebulagic acid from Terminalia chebula enhances insulin mediated glucose uptake in 3T3-L1 adipocytes via PPARγ signaling pathway.
Shyni GL; Kavitha S; Indu S; Arya AD; Anusree SS; Vineetha VP; Vandana S; Sundaresan A; Raghu KG
Biofactors; 2014; 40(6):646-57. PubMed ID: 25529897
[TBL] [Abstract][Full Text] [Related]
26. Insulinomimetic Zn complex (Zn(opt)2) enhances insulin signaling pathway in 3T3-L1 adipocytes.
Basuki W; Hiromura M; Sakurai H
J Inorg Biochem; 2007 Apr; 101(4):692-9. PubMed ID: 17316811
[TBL] [Abstract][Full Text] [Related]
27. The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo.
Li YY; Wu HS; Tang L; Feng CR; Yu JH; Li Y; Yang YS; Yang B; He QJ
Pharmacol Res; 2007 Oct; 56(4):335-43. PubMed ID: 17889553
[TBL] [Abstract][Full Text] [Related]
28. The extract of Cinnamomum cassia twigs inhibits adipocyte differentiation via activation of the insulin signaling pathway in 3T3-L1 preadipocytes.
Han Y; Jung HW; Bae HS; Kang JS; Park YK
Pharm Biol; 2013 Aug; 51(8):961-7. PubMed ID: 23627464
[TBL] [Abstract][Full Text] [Related]
29. PAM-1616, a selective peroxisome proliferator-activated receptor γ modulator with preserved anti-diabetic efficacy and reduced adverse effects.
Kim MK; Chae YN; Choi SH; Moon HS; Son MH; Bae MH; Choi HH; Hur Y; Kim E; Park YH; Park CS; Kim JG; Lim JI; Shin CY
Eur J Pharmacol; 2011 Jan; 650(2-3):673-81. PubMed ID: 20974124
[TBL] [Abstract][Full Text] [Related]
30. Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.
Nakano R; Kurosaki E; Yoshida S; Yokono M; Shimaya A; Maruyama T; Shibasaki M
Biochem Pharmacol; 2006 Jun; 72(1):42-52. PubMed ID: 16696951
[TBL] [Abstract][Full Text] [Related]
31. Pioglitazone upregulates adiponectin receptor 2 in 3T3-L1 adipocytes.
Kudoh A; Satoh H; Hirai H; Watanabe T
Life Sci; 2011 Jun; 88(23-24):1055-62. PubMed ID: 21514306
[TBL] [Abstract][Full Text] [Related]
32. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
[TBL] [Abstract][Full Text] [Related]
33. Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists.
Erbe DV; Gartrell K; Zhang YL; Suri V; Kirincich SJ; Will S; Perreault M; Wang S; Tobin JF
Vascul Pharmacol; 2006 Sep; 45(3):154-62. PubMed ID: 16765099
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia decreases insulin signaling pathways in adipocytes.
Regazzetti C; Peraldi P; Grémeaux T; Najem-Lendom R; Ben-Sahra I; Cormont M; Bost F; Le Marchand-Brustel Y; Tanti JF; Giorgetti-Peraldi S
Diabetes; 2009 Jan; 58(1):95-103. PubMed ID: 18984735
[TBL] [Abstract][Full Text] [Related]
35. Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma.
Young PW; Buckle DR; Cantello BC; Chapman H; Clapham JC; Coyle PJ; Haigh D; Hindley RM; Holder JC; Kallender H; Latter AJ; Lawrie KW; Mossakowska D; Murphy GJ; Roxbee Cox L; Smith SA
J Pharmacol Exp Ther; 1998 Feb; 284(2):751-9. PubMed ID: 9454824
[TBL] [Abstract][Full Text] [Related]
36. Puerarin enhances adipocyte differentiation, adiponectin expression, and antioxidant response in 3T3-L1 cells.
Lee OH; Seo DH; Park CS; Kim YC
Biofactors; 2010; 36(6):459-67. PubMed ID: 20806284
[TBL] [Abstract][Full Text] [Related]
37. Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells.
Maeda H; Hosokawa M; Sashima T; Takahashi N; Kawada T; Miyashita K
Int J Mol Med; 2006 Jul; 18(1):147-52. PubMed ID: 16786166
[TBL] [Abstract][Full Text] [Related]
38. c-Jun N-terminal kinase is involved in the suppression of adiponectin expression by TNF-alpha in 3T3-L1 adipocytes.
Kim KY; Kim JK; Jeon JH; Yoon SR; Choi I; Yang Y
Biochem Biophys Res Commun; 2005 Feb; 327(2):460-7. PubMed ID: 15629137
[TBL] [Abstract][Full Text] [Related]
39. Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation.
Nugent C; Prins JB; Whitehead JP; Savage D; Wentworth JM; Chatterjee VK; O'Rahilly S
Mol Endocrinol; 2001 Oct; 15(10):1729-38. PubMed ID: 11579205
[TBL] [Abstract][Full Text] [Related]
40. Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner.
Bonofiglio D; Qi H; Gabriele S; Catalano S; Aquila S; Belmonte M; Andò S
Endocr Relat Cancer; 2008 Jun; 15(2):545-57. PubMed ID: 18509005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
